Long-term outcome of resuming anticoagulation after anticoagulation-associated intracerebral hemorrhage

INTRODUCTION: The risk and benefit of restarting oral anticoagulation (OAC) therapy among patients with atrial fibrillation or flutter (AF) and an episode of anticoagulation-associated intracerebral hemorrhage (ICH) remain unclear. Whether or not to resume OAC after an OAC-associated ICH will remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadighi, Alireza, Wasko, Lisa, DiCristina, Heather, Wagner, Thomas, Wright, Kathryn, Capone, Kellie, Monczewski, Maureen, Kester, Margaret, Bourdages, George, Griessenauer, Christoph, Zand, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037578/
https://www.ncbi.nlm.nih.gov/pubmed/32123759
http://dx.doi.org/10.1016/j.ensci.2020.100222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037578/
https://www.ncbi.nlm.nih.gov/pubmed/32123759
http://dx.doi.org/10.1016/j.ensci.2020.100222

Ejemplares similares